FOXO1 controls CD20 expression and influences B-cell lymphoma response to rituximab-based immunotherapy.
Authors: Dwojak M., Pyrzynska B., Zerrouqi A., Morlino G., Zapala P., Miazek N., Bojarczuk K., Bobrowicz M., Machnicki M., Golab J., Calado D., Winiarska M.
Published in: Congress of the European Hematology Association (EHA)
Publication type: conference